Skip to main content

Table 2 Means and standard deviations by symptomatic diagnostic group (subjective cognitive decline or mild cognitive impairment), sex, and Aβ/P-tau status for demographics; memory and global cognitive scores, hippocampal and total intracranial volumes; and number of APOE ε4 carriers

From: Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume

 

Subjective cognitive decline (SCD)

Mild cognitive impairment (MCI)

Men

Women

Men

Women

Aβ/P-tau+

Aβ/P-tau−

Aβ/P-tau+

Aβ/P-tau−

Aβ/P-tau+

Aβ/P-tau−

Aβ/P-tau+

Aβ/P-tau−

(N = 34)

(N = 51)

(N = 25)

(N = 76)

(N = 74)

(N = 75)

(N = 63)

(N = 34)

Age

72.59 (5.37) a,b

70.22 (5.46) a,b

70.63 (4.84) a,b

69.78 (5.69) a,b

72.35 (5.13) a

69.59 (5.74) a

71.37 (4.88) a

69.76 (5.52) a

Education

11.71 (3.84) a

13.00 (3.59) a

11.60 (3.33) a

11.97 (3.30) a

11.62 (3.49) a

10.71 (3.48) a

11.44 (3.07) a

10.47 (3.13) a

ADAS Delayed Word Recall Omissions (/10)

4.12 (1.89)

3.38 (1.89)

5.06 (3.02)

4.73 (2.80)

6.91 (2.06) a

5.92 (2.10) a

7.43 (1.81) a

5.24 (2.69) a

MMSE total score

28.35 (1.54)

28.92 (1.29)

27.88 (1.88)

27.74 (1.73)

26.65 (1.67)

27.56 (1.85)

26.84 (1.79)

27.62 (1.88)

Total intracranial volume

1.7 × 106 (1.1 × 105)

1.7 × 106 (1.3 × 105)

1.5 × 106 (1.1 × 105)

1.5 × 106 (1.2 × 105)

1.7 × 106 (1.3 × 105)

1.7 × 106 (1.4 × 105)

1.5 × 106 (1.2 × 105)

1.5 × 106 (1.2 × 105)

Total hippocampal volume

7.2 × 103 (1.1 × 103)

7.7 × 103 (1.3 × 103)

6.8 × 103 (1.3 × 103)

6.7 × 103 (1.1 × 103)

6.7 × 103 (1.1 × 103)

7.2 × 103 (1.3 × 103)

6.1 × 103 (1.0 × 103)

6.6 × 103 (1.2 × 103)

APOE ε4 carriers

21 a

14 a

17 a

21 a

55 a

20 a

46 a

6 a

  1. Abbreviations: Aβ/P-tau+ amyloid beta/P-tau positive, ADAS Alzheimer’s Disease Assessment Scale, APOE apolipoprotein E, MMSE Mini-Mental State Examination
  2. aDiffers by Aβ/P-tau+ within diagnostic group, p < 0.05
  3. bDiffers by sex within diagnostic group, p < 0.05
  4. Significant differences in these variables by Aβ/P-tau status and sex within each diagnostic group are indicated by superscript